Cencora, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Robert P. Mauch
- Full Time Employees
- 51,000
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- 1 West First Avenue Conshohocken PA United States 19428-1800
- IPO Date
- May 28, 1996
- CIK
- 0001140859
- Website
- cencora.com
- Similar Companies
- Business
- Cencora, Inc. (NYSE: COR) serves as a leading global pharmaceutical solutions organization that provides end-to-end pharmaceutical distribution, commercialization support, and related services to manufacturers, healthcare providers, pharmacies, hospitals, and health systems worldwide. Founded in 1871 and headquartered in Conshohocken, Pennsylvania, the company operates through U.S. Healthcare Solutions and International Healthcare Solutions segments; it distributes brand-name, specialty brand-name, generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment; offers wholesale and specialty distribution, pharmacy solutions, provider solutions, hospital and health system solutions, logistics and warehousing, drug research and clinical development support, commercialization support, and patient access and adherence programs; and serves acute care hospitals, independent and chain retail pharmacies, mail-order facilities, physicians, clinics, long-term care, assisted living centers, workers' compensation patients, and alternate site facilities across the United States, Canada, and other international markets. In recent developments, Cencora changed its name from AmerisourceBergen Corporation in August 2023; entered a definitive agreement in November 2024 to acquire Retina Consultants of America, a management services organization for retina specialists, for approximately $4.6 billion in cash plus up to $500 million in contingent consideration to expand its specialty capabilities and physician relationships; and announced in November 2025 a $1 billion investment through 2030 to strengthen its U.S. distribution network, including a new 530,000-square-foot national distribution center in Harrison, Ohio by spring 2027, expansions in Fontana, California and Dothan, Alabama with advanced automation and increased refrigerated capacity, and enhanced global cold chain logistics with a new third-party logistics facility planned in Italy in 2026.
Company News
What Cencora (COR) Said on Its Q4 Earnings Call
Cencora Q4 Earnings & Revenues Beat on Specialty Growth, Margins Expand
Cencora, Inc. (COR) Q4 2026 Earnings Call Transcript
Cencora (COR) Reports Q4 Earnings: What Key Metrics Have to Say
Cencora (COR) Surpasses Q4 Earnings and Revenue Estimates
Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus
Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results
Why Cencora (COR) is a Top Growth Stock for the Long-Term
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Lumentum Holdings Inc. (Nasdaq – LITE), Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC)
Emerson Among 14 Dividend Growth Companies To Announce Annual Dividend Increases In First Half Of November
Cencora Gears Up to Report Q4 Results: How to Play the Stock?
Unveiling Cencora (COR) Q4 Outlook: Wall Street Estimates for Key Metrics
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth
Cencora to Acquire AON in $2.4B Deal to Expand Oncology Network
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ)
Disney's multiplatform Super Bowl plan frustrates ABC affiliates
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD)
Cencora to acquire American Oncology Network in $2.4 billion deal
Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology
IFP Advisors Inc Purchases 14,078 Shares of Cencora, Inc. $COR